Current therapies for treatment of cutaneous leishmaniasis in India.
Dogra
J
J
D000935:Antifungal Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D005455:Fluorescent Antibody Technique; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D016052:Protozoan Vaccines / Q000592:standards; D012882:Skin Tests
D000935:Antifungal Agents; D000981:Antiprotozoal Agents; D016052:Protozoan Vaccines; D017964:Itraconazole; D003622:Dapsone; D007654:Ketoconazole